XML 22 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Compensation
12 Months Ended
Dec. 31, 2011
Share-Based Compensation  
Share-Based Compensation

16.  Share-Based Compensation

 

The Company accounts for all share-based payments to employees and directors, including grants of employee stock options, at fair value and expenses the benefit in the Consolidated Statements of Operations over the service period (generally the vesting period).  The fair value of each stock option granted is estimated on the date of grant using the Black-Scholes pricing valuation model, which requires various assumptions including estimating stock price volatility, expected life of the stock option and risk free interest rate.  The Company applies an estimated forfeiture rate in calculating the period expense.  The Company has not experienced any forfeitures that would need to be taken into consideration in its calculations.

 

The Company has three stock option plans.  Under the 1995 Stock Option Plan, 125,000 shares of Common Stock were authorized for grant to key employees.  Under the Non-Employee Director Stock Option Plan, 30,000 shares of Common Stock were authorized for grant.  Under the Non-Statutory Stock Option Agreement, 10,000 shares of Common Stock were authorized and issued to the former Chairman of the Board.

 

Changes in the stock option plans are as follows:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

Number of Shares

Average

 

 

 

 

 

 

 

 

 

Authorized

 

Granted

 

 

Available

 

 

Exercise Price

Balance  January 1,2010

 

 

 

 

 

 

39,000

 

26,000

 

 

13,000

 

 

$4.57

Expired

 

 

 

 

 

 

          -

(3,000)

3,000

5.03

Granted

 

 

 

 

 

 

          -

 

          -

 

 

-           

Balance December  31, 2010

 

 

 

 

 

 

39,000

 

23,000

 

 

16,000

4.51

Expired

 

 

 

 

 

 

(10,000)

(11,000)

1,000

3.97

Granted

 

 

 

 

 

 

          -

 

          -

 

 

Balance December 31, 2011

 

 

 

 

 

 

 

 

29,000

 

12,000

 

 

17,000

 

 

4.99

 

 

Under the 1995 Stock Option Plan, option prices must be at least 100% of the market value of the Common Stock at time of grant.  No option may be exercised prior to one year after date of grant.  Exercise periods are for ten years from date of grant and terminate at a stipulated period of time after an employee’s termination of employment.  At December 31, 2011, options for 7,500 shares with exercise prices ranging from $6.10 to $7.00 per share were outstanding, all of which were exercisable.  During 2011 and 2010, no options were exercised, granted or expired.  No additional options can be granted under the 1995 Plan.

 

Under the Non-Employee Director Stock Option Plan, option prices must be at least 100% of the market value of the Common Stock at time of grant.  No option may be exercised prior to one year after date of grant and the optionee must be a director of the Company at time of exercise, except in certain cases as permitted by the Compensation Committee.  Exercise periods are for six years from date of grant and terminate at a stipulated period of time after an optionee ceases to be a director.  At December 31, 2011, options for 4,500 shares with exercise prices ranging from $0.65 to $5.95 per share were outstanding, all of which were exercisable.  During 2011, no options were granted and options for 1,000 shares expired; no options were exercised.  During 2010, no options were granted and options for 3,000 shares expired; no options were exercised.

 

Under the Non-Statutory Stock Option Agreement for the former Chairman of the Board, the option price must be at least 100% of the market value of the Common Stock at time of grant and the exercise period is for 10 years from date of grant.  At December 31, 2011, no options were outstanding.  During 2011, the option for 10,000 shares expired and no options were exercised or granted.  During 2010, no options were exercised, granted or expired.

 

The following table summarize information about stock options outstanding and exercisable at December 31, 2011:

 

Range of Exercise Prices

 

 

Number Outstanding and Exercisable

 

 

Weighted Average Remaining Contractual Life

 

 

Weighted Average Exercise Price

 

 

Aggregate Intrinsic Value

 

 

 

 

 

 

 

$0.65 - $1.99

 

 

3,000

 

 

3.6

 

              $0.92

 

 

-

2.00 - 5.99

 

 

1,500

 

 

1.9

 

                4.55

 

 

-

6.00 - 6.99

 

 

2,500

 

 

0.5

 

                6.10

 

 

-

7.00 - 7.99

 

 

5,000

 

 

2.3

 

                7.00

 

 

-

 

 

 

 

12,000

 

 

 

2.2

 

 

                4.99

 

 

 

-

 

All outstanding option prices are over the current market price.  As of December 31, 2011, there was no unrecognized compensation cost related to non-vested options granted under the Plans.

 

No options were granted in 2011 and 2010.  The fair value of options granted under the Company’s stock option plans will be estimated on dates of grant using the Black-Scholes model using the weighted average assumptions for dividend yield, expected volatility, risk free interest rate and expected lives of options granted.